Remote Patient Monitoring Patch Global Market Report 2025

The remote patient monitoring patch market size has grown rapidly in recent years. It will grow from $2.03 billion in 2024 to $2.37 billion in 2025 at a compound annual growth rate (CAGR) of 16.7%. The growth during the historic period can be attributed to the aging population and increasing life expectancy, the growing prevalence of chronic cardiovascular and metabolic diseases, hospital capacity limitations and bed shortages, the transition toward value-based care and outcome-based reimbursement, and the implementation of remote physiologic monitoring billing codes.

The remote patient monitoring patch market size is expected to see rapid growth in the next few years. It will grow to $4.35 billion in 2029 at a compound annual growth rate (CAGR) of 16.3%. The growth during the forecast period can be attributed to the increasing prevalence of cardiovascular diseases and associated risk factors, the expansion of hospital-at-home and community-based care models, the stabilization and broadening of remote physiologic monitoring reimbursement, the emphasis on cost containment among payers and providers, and the incorporation of continuous monitoring into clinical guidelines and care pathways. Key trends in the forecast period include AI-powered predictive analytics, multi-parameter monitoring, the development of flexible and biocompatible materials, cloud-based data integration, and the integration of mobile health applications with ECG devices.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the remote patient monitoring patch market in the coming years. Cardiovascular diseases refer to a group of disorders affecting the heart and blood vessels, including coronary heart disease, cerebrovascular disease, and other circulatory system conditions. The rise in cardiovascular diseases is primarily attributed to sedentary lifestyles, which reduce physical activity and contribute to obesity and high blood pressure, thereby increasing the risk of heart-related conditions. A remote patient monitoring patch aids in managing cardiovascular diseases by continuously tracking vital signs such as heart rate, rhythm, blood pressure, and oxygen levels, allowing early detection of irregularities and timely intervention to prevent complications. For example, in October 2024, according to the Centers for Disease Control and Prevention, a United States-based national public health agency, approximately 919,032 people in the United States died from cardiovascular disease in 2023, accounting for nearly one in every three deaths nationwide. Therefore, the rising prevalence of cardiovascular diseases is propelling the growth of the remote patient monitoring patch market.

Leading companies in the remote patient monitoring patch market are focusing on developing advanced products, such as ECG monitoring systems powered by AI algorithms, to enable real-time cardiac monitoring and enhance patient management. These AI-powered ECG monitoring systems are wearable devices that continuously record heart activity and utilize artificial intelligence to analyze data in real time, detecting irregularities and predicting potential cardiac events to support timely medical intervention. For instance, in May 2025, iRhythm Technologies, Inc., a United States-based digital health company, launched the Zio Long-Term Continuous Monitoring Service in Japan, featuring a patch-based electrocardiogram recording and analysis system. This solution provides up to fourteen days of continuous, uninterrupted ECG monitoring supported by a deep-learned AI algorithm approved by Japan’s Pharmaceuticals and Medical Devices Agency. It represents a significant advancement in arrhythmia detection compared to traditional 24-48-hour Holter monitors and other short-duration patch systems, addressing the rising need for early and accurate arrhythmia diagnosis among Japan’s aging population.

In May 2024, WearLinq, a United States-based wearable cardiac-monitoring medical device company, acquired AMI Cardiac Monitoring for an undisclosed amount. Through this acquisition, WearLinq aims to expand its clinical services nationwide and enhance access to its United States Food and Drug Administration 510(k)-cleared six-lead electrocardiogram patch. By integrating its patch technology and software with AMI’s Medicare-certified independent diagnostic testing facility operations and continuous technician support, the company seeks to accelerate patient onboarding, payer contracting, and physician workflow integration for remote patient monitoring patch programs. AMI Cardiac Monitoring is a United States-based company specializing in wearable ECG patch solutions.

Major players in the remote patient monitoring patch market are Samsung Electronics Co. Ltd., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Koninklijke Philips N.V., Baxter International Inc., Smith & Nephew plc, Dexcom Inc., iRhythm Technologies Inc., Bittium Corporation, Sibel Health Inc., Senseonics Holdings Inc., VitalConnect Inc., VivaLNK Inc., Biotricity Inc., BioIntelliSense Inc., Tenovi Inc., Icentia Inc., SmartCardia SA, ATsens Inc.

North America was the largest region in the remote patient monitoring patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in remote patient monitoring patch report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The remote patient monitoring patch market research report is one of a series of new reports that provides remote patient monitoring patch market statistics, including remote patient monitoring patch industry global market size, regional shares, competitors with a remote patient monitoring patch market share, detailed remote patient monitoring patch market segments, market trends and opportunities, and any further data you may need to thrive in the remote patient monitoring patch industry. The remote patient monitoring patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

A remote patient monitoring patch is a thin, adhesive wearable device designed to continuously track physiological signals from the body and transmit real-time health data to connected systems. It allows continuous, non-invasive monitoring, enabling instant detection of changes in patient health. This patch supports proactive medical decision-making and improves overall care efficiency through uninterrupted data transmission.

The primary product types of remote patient monitoring patches include vital sign monitoring patches, cardiac monitoring patches, temperature monitoring patches, and others. The vital sign monitoring patch continuously measures physiological parameters such as heart rate, blood pressure, and oxygen saturation to deliver real-time health insights. These patches are distributed through both online and offline channels and are utilized in various applications, including chronic disease management, post-acute care, fitness and wellness, and others. They are used by multiple end-users such as hospitals and clinics, home care settings, ambulatory surgical centers, and others.

The countries covered in the remote patient monitoring patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The remote patient monitoring patch market consists of sales of respiratory monitoring patches, glucose monitoring patches, hydration monitoring patches, stress monitoring patches, and motion and activity monitoring patches. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.